Referral for BRCA Genetic Testing in Breast Nodule
Patients with a breast nodule concerning for cancer should be referred to a genetic counselor or appropriately trained healthcare professional (including oncologists, breast surgeons, or primary care physicians with genetics training) for BRCA genetic counseling and testing. 1, 2
Who Can Provide Genetic Counseling and Testing
Multiple trained specialists can appropriately manage BRCA genetic testing:
- Genetic counselors (traditional model)
- Medical geneticists
- Oncologists with genetics training 3
- Breast surgeons with genetics expertise 4
- Trained primary care providers 1
- Specialized breast clinical nurse specialists 5
The key requirement is that the provider has appropriate training in genetic counseling, can interpret complex test results, and can provide both pretest and posttest counseling. 1
Practical Referral Pathway
The most efficient model involves:
- Initial assessment by the oncologist or breast surgeon who discusses genetic testing and obtains informed consent 3
- Close collaboration with a genetics consultant who reviews results, particularly for variants of uncertain significance (VUS) 3
- Referral to specialized genetics clinic for patients with positive results, VUS, or strong family history requiring detailed risk assessment 3
Important Timing Considerations
- Genetic counseling should be offered preferably before starting treatment 2
- Fast-track processes should be available when results could change therapeutic approach (e.g., indication for risk-reducing surgery, PARP inhibitors) 2
- Primary treatment should not be delayed for genetic counseling referral 6
- Testing can occur at any time, but earlier results inform surgical and systemic therapy decisions 6, 7
Critical Pitfalls to Avoid
Do not assume traditional genetics clinics are the only option. The traditional model of referring all patients to genetics clinics is no longer sustainable given the expanded testing criteria and shortage of genetic counselors nationally 7. Many patients can be appropriately counseled and tested by their treating oncologist or breast surgeon with genetics training.
Ensure the provider understands VUS interpretation. Approximately 5-20% of BRCA tests return variants of uncertain significance, which are frequently misinterpreted, leading to overestimation of cancer risk and inappropriate preventive surgeries 3. Providers must have access to genetics consultation for complex results.
Recognize that most primary care physicians underutilize genetic testing. Studies show less than 25% of primary care physicians ever refer patients for BRCA testing, and the majority of high-risk patients are not referred 8. Direct referral to breast specialists or genetics services may be more effective.
Who Should Be Tested
Current guidelines recommend genetic counseling and testing for women with:
- Breast cancer diagnosed at age ≤50 years
- Triple-negative breast cancer at age ≤60 years
- Multiple breast primaries
- Ovarian, fallopian tube, or peritoneal cancer at any age
- Male breast cancer
- Ashkenazi Jewish ancestry with breast cancer at any age
- Strong family history (≥3 cases of breast/ovarian/pancreatic cancer) 1, 6, 9
Recent guidelines from ASCO-SSO (2024) support offering BRCA1/2 testing to all patients with newly diagnosed breast cancer, regardless of age or family history 7. This reflects recognition that traditional criteria miss many mutation carriers.
Essential Components of Counseling
Pretest counseling must include:
- Risks, benefits, and limitations of testing
- Possible test outcomes (positive, negative, VUS, uninformative)
- Implications for the patient and family members
- Impact on treatment decisions and surveillance
- Voluntary nature of testing and informed consent requirements 1, 6
Posttest counseling is essential due to complexity of results interpretation 1.